Filtros de búsqueda

Lista de obras de Jorge Castillo

"All the soarings of my mind begin in my blood:" central nervous system complication of Waldenström macroglobulinemia

artículo científico publicado en 2016

A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia

scientific article published on 29 January 2020

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

scientific article published on 18 February 2020

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

artículo científico publicado en 2009

Acute Myeloid Leukemia Evolving from JAK 2-Positive Primary Myelofibrosis and Concomitant CD5-Negative Mantle Cell Lymphoma: A Case Report and Review of the Literature

artículo científico

Are we training our fellows adequately in delivering bad news to patients? A survey of hematology/oncology program directors

artículo científico publicado en 2009

Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies

artículo científico publicado en 2010

Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemia

artículo científico publicado en 2016

Bing-Neel syndrome: a rare complication of Waldenström macroglobulinemia

artículo científico publicado en 2015

Biology, prognosis, and therapy of Waldenström Macroglobulinemia

artículo científico publicado en 2015

Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma

artículo científico publicado en 2015

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma

artículo científico publicado en 2018

Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients.

artículo científico publicado en 2013

CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies

artículo científico publicado en 2011

CD20-negative diffuse large B-cell lymphoma presenting with lactic acidosis

artículo científico publicado en 2015

CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options

artículo científico publicado en 2015

CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia

artículo científico publicado en 2019

CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenström macroglobulinaemia cells

artículo científico publicado en 2014

CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib

scientific article published on 03 July 2019

CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors

scientific article published on 13 January 2020

CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic review

scientific article published on 30 July 2019

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia

artículo científico publicado en 2014

Cellular immunotherapy for refractory hematological malignancies

artículo científico publicado en 2013

Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

artículo científico publicado en 2015

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

artículo científico publicado en 2016

Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.

artículo científico publicado en 2016

Cigarette smoking is associated with a small increase in the incidence of non-Hodgkin lymphoma: a meta-analysis of 24 observational studies

artículo científico publicado en 2012

Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma

artículo científico publicado en 2010

Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study.

artículo científico publicado en 2018

Clinicopathologic characteristics and survival of patients with primary effusion lymphoma

scientific article published on 25 May 2020

Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia

artículo científico publicado en 2015

Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemia.

artículo científico publicado en 2017

Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database ⬇️

artículo científico publicado el 24 de enero de 2013

Comparing apples to oranges: A commentary on the Mayo study of MYD88 significance in Waldenstrom's macroglobulinemia

artículo científico publicado en 2017

Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature

scientific article published on December 2010

Current knowledge on HIV-associated Plasmablastic Lymphoma.

artículo científico publicado en 2014

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

artículo científico publicado en 2016

Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia

artículo científico publicado en 2015

Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemia

artículo científico publicado en 2019

Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance

scientific article published on 10 February 2014

Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies

artículo científico publicado en 2008

Diagnosis and management of hyponatremia in cancer patients

artículo científico publicado en 2012

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

scientific article published on 19 April 2020

Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma.

artículo científico publicado en 2010

Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriers

artículo científico publicado en 2011

EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier

artículo científico publicado en 2009

EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management

artículo científico publicado en 2016

EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru

artículo científico publicado en 2011

EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management

artículo científico publicado en 2018

EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management

scientific article published on 18 February 2020

EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals

scientific article published on 01 September 2011

Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma

artículo científico publicado en 2010

Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.

artículo científico publicado en 2011

Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.

artículo científico publicado en 2011

Erythrocyte membrane fatty acids in multiple myeloma patients.

artículo científico publicado en 2014

Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.

artículo científico publicado en 2016

Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia.

artículo científico publicado en 2016

Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas

scientific article published on 01 January 2020

Extramedullary Waldenström macroglobulinemia

artículo científico publicado en 2014

Extramedullary relapse of acute myeloid leukemia in a surgical wound

artículo científico publicado en 2010

Extranodal marginal zone lymphoma of the cranial dura mater: report of three cases and systematic review of the literature

artículo científico publicado en 2013

Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literature

artículo científico

Future therapeutic options for patients with Waldenström macroglobulinemia

artículo científico publicado en 2016

Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia

scientific article published on 27 February 2020

Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome

artículo científico publicado en 2016

HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases

scientific article published on October 2008

HIV-negative plasmablastic lymphoma: not in the mouth

artículo científico publicado en 2011

HOLA! from Latin America to the myeloma world

artículo científico publicado en 2019

Hematopoietic SCT for adult T-cell leukemia/lymphoma: a review.

artículo científico publicado en 2011

Hematopoietic cell transplantation for plasmablastic lymphoma: a review.

artículo científico publicado en 2014

Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies

artículo científico publicado en 2013

Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia

artículo científico publicado en 2016

How we manage Bing-Neel syndrome

artículo científico publicado en 2019

Human Immunodeficiency Virus-associated anaplastic large cell lymphoma

artículo científico publicado en 2010

Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base

artículo científico publicado en 2016

Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.

artículo científico publicado en 2012

Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound.

artículo científico publicado en 2017

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

artículo científico publicado en 2016

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

artículo científico publicado en 2018

Ibrutinib in previously treated Waldenström's macroglobulinemia.

artículo científico publicado en 2015

Idelalisib in Waldenström macroglobulinemia: high incidence of hepatotoxicity

artículo científico publicado en 2016

IgM myeloma: A multicenter retrospective study of 134 patients

artículo científico publicado en 2017

Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2010

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

artículo científico publicado en 2014

Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma

artículo científico publicado en 2014

Improving the accuracy in prognosis for Burkitt lymphoma patients.

artículo científico publicado en 2013

Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.

artículo científico publicado en 2015

Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies

artículo científico publicado en 2012

Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders

artículo científico publicado en 2016

Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia

artículo científico publicado en 2018

Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies

artículo científico publicado en 2014

Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up

artículo científico publicado en 2020

Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus?

artículo científico publicado en 2014

Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas

artículo científico publicado en 2017

Long survival in patients with Waldenström macroglobulinaemia diagnosed at a young age

artículo científico publicado en 2018

Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenström macroglobulinaemia

artículo científico publicado en 2018

Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib

artículo científico publicado en 2018

Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified

artículo científico publicado en 2010

MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia.

artículo científico publicado en 2016

MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival

artículo científico publicado en 2017

Management of hematological malignancies during pregnancy

artículo científico publicado en 2009

Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's Lymphoma

artículo científico publicado en 2011

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases

scientific article published on 22 July 2018

Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality

artículo científico

Newer monoclonal antibodies for hematological malignancies.

artículo científico publicado en 2008

No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies

artículo científico publicado en 2012

Not All Aggressive Adult T-Cell Leukemia/Lymphoma Subtypes Are Created Equal ⬇️

artículo científico publicado el 27 de agosto de 2012

Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.

artículo científico publicado en 2017

Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies

artículo científico publicado en 2012

Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies

artículo científico publicado en 2013

Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia

artículo científico publicado en 2014

Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia ⬇️

artículo científico publicado el 1 de febrero de 2011

Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders

artículo científico publicado en 2009

Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy.

artículo científico publicado en 2016

Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma

artículo científico publicado en 2019

Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database

artículo científico publicado en 2014

PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies

artículo científico

Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib

artículo científico publicado en 2020

Peripheral T-cell lymphoma with a regulatory T-cell phenotype: report of a nodal and an extranodal case from Peru.

artículo científico

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy

artículo científico publicado en 2014

Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia

artículo científico publicado en 2015

Plasma Cell Disorders

artículo científico publicado en 2016

Plasma fatty acid profile in multiple myeloma patients.

artículo científico publicado en 2014

Plasmablastic Lymphoma: A Systematic Review ⬇️

artículo científico publicado el 22 de marzo de 2011

Plasmablastic lymphoma: Are more intensive regimens needed? ⬇️

artículo científico publicado el 23 de julio de 2011

Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.

artículo científico publicado en 2013

Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis

artículo científico publicado en 2011

Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study

artículo científico publicado en 2015

Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?

artículo científico publicado en 2017

Primary refractory Hodgkin lymphoma: Limited options and poor survival-but not always

artículo científico publicado en 2014

Primary refractory multiple myeloma: a real-world experience with 85 cases

artículo científico publicado en 2020

Prognosis in primary effusion lymphoma is associated with the number of body cavities involved

artículo científico

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud

artículo científico publicado en 2014

Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.

artículo científico publicado en 2010

Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study

artículo científico publicado en 2011

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.

artículo científico publicado en 2018

Prospective clinical trial of ixazomib, dexamethasone and rituximab as primary therapy in Waldenström macroglobulinemia.

artículo científico publicado en 2018

R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies

article

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

artículo científico publicado en 2016

Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials

artículo científico publicado en 2015

Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes

artículo científico publicado en 2016

Reply to A. Messori et al ⬇️

artículo científico publicado el 12 de marzo de 2013

Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma

artículo científico publicado en 2017

Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia

artículo científico publicado en 2018

Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

artículo científico publicado en 2016

Risk factors associated with Clostridium difficile infection in adult oncology patients with a history of recent hospitalization for febrile neutropenia

artículo científico publicado en 2012

Risk factors for progression from smoldering into active myeloma: additional insights from a population-based study

artículo científico publicado en 2016

Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies.

artículo científico publicado en 2012

Rituximab intolerance in patients with Waldenström macroglobulinaemia

artículo científico publicado en 2015

SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas

artículo científico publicado en 2020

Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance

artículo científico publicado en 2016

Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients

artículo científico publicado en 2018

Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia

artículo científico publicado en 2017

Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP.

artículo científico publicado en 2013

Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database

artículo científico publicado en 2014

Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype

artículo científico publicado en 2013

Spotting the elusive Siberian tiger: Complete response to ibrutinib in a patient with Waldenström Macroglobulinemia

artículo científico publicado en 2018

Survival Claims From Observational Data on Cancer Therapy

artículo científico publicado en 2016

Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base.

artículo científico publicado en 2017

Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database

artículo científico publicado en 2012

Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.

artículo científico publicado en 2015

Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database.

artículo científico publicado en 2014

Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies

artículo científico publicado en 2014

Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia

artículo científico publicado en 2016

Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru

scientific article published on 26 September 2014

The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cells

artículo científico publicado en 2015

The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients

scientific article published on 17 April 2020

The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.

artículo científico publicado en 2012

The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia.

artículo científico publicado en 2014

The biology and treatment of plasmablastic lymphoma.

artículo científico publicado en 2015

The girl with the iron tattoo

artículo científico publicado en 2012

The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma

artículo científico publicado en 2018

The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified.

artículo científico publicado en 2015

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients

artículo científico publicado en 2016

The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies

artículo científico publicado en 2014

The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies

artículo científico publicado en 2010

To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenström Macroglobulinaemia.

artículo científico publicado en 2016

Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.

artículo científico publicado en 2016

Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma

artículo científico publicado en 2016

Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

artículo científico publicado en 2016

Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base

artículo científico publicado en 2015

Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base.

artículo científico publicado en 2015

Viral lymphomagenesis: beyond the usual suspects

scientific article published on 29 May 2018

Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies

artículo científico

Waldenström Macroglobulinemia

artículo científico publicado en 2014

What is new in the treatment of Waldenstrom macroglobulinemia?

artículo científico publicado en 2019

Why is My Patient Neutropenic?

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda